We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Chouinard, G., De Montigny, C. & Annable, L. (1979) Tardive dyskinesia and anti-Parkinsonian medication. American Journal of Psychiatry, 136, 228–229.Google Scholar
Gerlach, J. (1977) The relationship between Parkinsonism and tardive dyskinesia. American Journal of Psychiatry, 134, 781–784.Google Scholar
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. United States Department of Health, Education and Welfare, 534–537.Google Scholar
Kidger, T., Barnes, T. R. E., Trauder, T. & Taylor, P. J. (1980) Sub-syndromes of tardive dyskinesia. Psychological Medicine, 10, 513–520.Google Scholar
McCreadie, R. G., Barron, E. T. & Winslow, G. S. (1982) The Nithsdale schizophrenia survey: II Abnormal movements. British Journal of Psychiatry, 140, 587–590.Google Scholar
Marsden, C. D. & Jenner, P. (1980) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychological Medicine, 10, 55–72.Google Scholar
Webster, D. D. (1968) Critical analysis of the disability of Parkinson's disease. Modern Treatments, 5, 257–282.Google Scholar
eLetters
No eLetters have been published for this article.